Evidence map›Paper›PMID 29526171›Full record

ArticleEpidemiology and infection2018

The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014.

D Y W Chan, W J Edmunds, H L Chan, V Chan, Y C K Lam, S L Thomas, A J van Hoek, S Flasche

Abstract read
In one paragraph

Article in Epidemiology and infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Global varicella vaccination programs.Clinical and experimental pediatrics · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

D Y W ChanCommunicable Disease Division,Surveillance and Epidemiology Branch,Department of Health,Centre for Health Protection,Hong Kong,Hong Kong SAR.
W J EdmundsDepartment of Infectious Disease Epidemiology,Faculty of Epidemiology and Population Health,London School of Hygiene and Tropical Medicine,London,UK.
H L ChanCommunicable Disease Division,Surveillance and Epidemiology Branch,Department of Health,Centre for Health Protection,Hong Kong,Hong Kong SAR.
V ChanCommunicable Disease Division,Surveillance and Epidemiology Branch,Department of Health,Centre for Health Protection,Hong Kong,Hong Kong SAR.
Y C K LamCommunicable Disease Division,Surveillance and Epidemiology Branch,Department of Health,Centre for Health Protection,Hong Kong,Hong Kong SAR.
S L ThomasDepartment of Infectious Disease Epidemiology,Faculty of Epidemiology and Population Health,London School of Hygiene and Tropical Medicine,London,UK.
A J van HoekDepartment of Infectious Disease Epidemiology,Faculty of Epidemiology and Population Health,London School of Hygiene and Tropical Medicine,London,UK.
S FlascheDepartment of Infectious Disease Epidemiology,Faculty of Epidemiology and Population Health,London School of Hygiene and Tropical Medicine,London,UK.

Funding

Wellcome TrustWellcome Trust 208812/Z/17/Z
6 · The paper itself

Abstract

In Hong Kong, universal varicella vaccination started in July 2014. Before this, children could receive varicella vaccine via the private market. We analysed the epidemiology of varicella and zoster before universal vaccination. We estimated varicella vaccination coverage through surveys in preschool children. We estimated the burden of varicella and zoster with varicella notifications from 1999/00 to 2013/14, Accident and Emergency Department (A&E) attendance and inpatient admissions to public hospitals from 2004/05 to 2013/14. We fitted a catalytic model to serological data on antibodies against varicella-zoster virus to estimate the force of infection. We found that varicella vaccination coverage gradually increased to about 50% before programme inception. In children younger than 5 years, the annual rate of varicella notifications, varicella admission and zoster A&E attendance generally declined. The annual notification, A&E attendance and hospitalisation rate of varicella and zoster generally increased for individuals between 10 and 59 years old. Varicella serology indicated an age shift during the study period towards a higher proportion of infections in slightly older individuals, but the change was most notable before vaccine licensure. In conclusion, we observed a shift in the burden of varicella to slightly older age groups with a corresponding increase in incidence but it cannot necessarily be attributed to private market vaccine coverage alone. Increasing varicella vaccination uptake in the private market might affect varicella transmission and epidemiology, but not to the level of interrupting transmission.

Indexed as

AdolescentAdultAgedAntibodies, ViralChickenpoxChickenpox VaccineChildChild, PreschoolDisease NotificationDisease Transmission, InfectiousFemaleHerpesvirus 3, HumanHerpes ZosterHong KongHospitalizationHumansAntibodies, ViralChickenpox VaccineChickenpoxsurveillancevaccinesvaricella zosterzoster (shingles)

Identifiers

PMID29526171
PMCPMC6533643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.